Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Jonathan R. Day"'
Autor:
Evan M. Bloch, Jonathan R. Day, Peter J. Krause, Anne Kjemtrup, Sheila F. O’Brien, Aaron A.R. Tobian, Ruchika Goel
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 2, Pp 354-362 (2022)
Babesia spp. are tickborne parasites that cause the clinical infection babesiosis, which has an increasing incidence in the United States. We performed an analysis of hospitalizations in the United States during 2010–2016 in which babesiosis was li
Externí odkaz:
https://doaj.org/article/3d5afd7f39574fe0b121f5f2cdb31089
Autor:
Jonathan R. Day, Benjamin Miller, Bradley T. Loeffler, Sarah L. Mott, Munir Tanas, Melissa Curry, Jonathan Davick, Mohammed Milhem, Varun Monga
Publikováno v:
Frontiers in Psychology, Vol 13 (2022)
BackgroundSarcomas are a diverse group of neoplasms that vary greatly in clinical presentation and responsiveness to treatment. Given the differences in the sites of involvement, rarity, and treatment modality, a multidisciplinary approach is require
Externí odkaz:
https://doaj.org/article/ab5e74da26294c69ad335f9bfb4bc074
Autor:
Jonathan R Day, Melissa C. Larson, Carla Casulo, Yucai Wang, Dai Chihara, Brad S. Kahl, Peter Martin, Izidore S. Lossos, Victor M. Orellana-Noia, Richard Burack, Jonathan W. Friedberg, Thomas M. Habermann, James R. Cerhan, Christopher R. Flowers, Matthew J. Maurer, Brian K. Link
Publikováno v:
Blood. 140:6642-6644
Autor:
Jonathan R. Day, Clifford Takemoto, Anjali Sharathkumar, Sarah Makhani, Ashwin Gupta, Stephanie Bitner, Cassandra D. Josephson, Evan M. Bloch, Aaron A. R. Tobian, Lakshmanan Krishnamurti, Ruchika Goel
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 28(4)
Current in-hospital burden and healthcare utilization patterns for persons with haemophilia (PWH) A and B, including both children (ages 18 years) and adults (ages ≥ 18 years), in the United States (US) are lacking.To evaluate healthcare utilizatio
Autor:
Jonathan R, Day, Brian K, Link
Publikováno v:
Oncology (Williston Park, N.Y.). 36(2)
Jonathan R. Day, MD, PharmD, and Brian K. Link, MD, give their perspective on emerging treatments for follicular lymphoma.
Autor:
Carla Casulo, Melissa C. Larson, Jonathan R Day, Thomas Matthew Habermann, Izidore S. Lossos, Yucai Wang, Loretta J. Nastoupil, Christopher Strouse, Dai Chihara, Peter Martin, Jonathon Brett Cohen, Brad S. Kahl, Jia Ruan, Walter Richard Burack, Jean Louise Koff, Jonathan W. Friedberg, James Robert Cerhan, Christopher Flowers, Brian K. Link, Matthew J. Maurer
Publikováno v:
Journal of Clinical Oncology. 40:7573-7573
7573 Background: While most patients (pts) with follicular lymphoma (FL) usually have favorable outcomes, those with refractory disease after first-line anti-CD20 based immunochemotherapy (IC), or progression within 24 months of diagnosis (POD24) hav
Autor:
Ruchika Goel, Ashwin Gupta, Jonathan R Day, Clifford Takemoto, Kyungsuk Jung, Calvin Abro, Lakshmanan Krishnamurti
Publikováno v:
Blood. 136:30-31
Introduction: Comprehensive management for patients with hemophilia has drastically improved outcomes, quality of care, and longevity. Because of increases in life span, patients with hemophilia may be at risk for other chronic conditions including c
Autor:
Eric A. Gehrie, Ruchika Goel, Calvin Abro, Ashwin Gupta, Aaron A.R. Tobian, Michael B. Streiff, Clifford Takemoto, Kyungsuk Jung, Jonathan R Day, Evan M. Bloch
Publikováno v:
Blood. 136:39-40
Introduction Venous thromboembolism (VTE) (deep vein thrombosis [DVT] and pulmonary embolism [PE]) is a cause of significant morbidity and mortality. Over the last decade, there has been an increase in awareness and major advances in early diagnosis
Autor:
Varun Monga, Sarah L. Mott, Munir R. Tanas, Mohammed M. Milhem, Benjamin J. Miller, Melissa Curry, Jonathan R. Day, Jonathan Davick, Bradley T. Loeffler
Publikováno v:
Journal of Clinical Oncology. 39:e23557-e23557
e23557 Background: Sarcomas are a diverse group of neoplasms that vary greatly in clinical presentation and responsiveness to treatment. Given the differences in the sites of involvement, rarity, and treatment modality, a multidisciplinary approach i
Publikováno v:
Handbook of Hematologic Malignancies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb20346b5429ff87df075ed7c7736910
https://doi.org/10.1891/9781617052705.0054
https://doi.org/10.1891/9781617052705.0054